Home
Conditions
Neurofibrosarcoma

Clinical trial condition

Neurofibrosarcoma

Explore clinical trials studying Neurofibrosarcoma. Study availability and eligibility vary by location and protocol.

73 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Neurofibrosarcoma trial results

Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions: Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations: Stanford University Palo Alto, California, United States

Grand Valley Oncology Grand Junction, Colorado, United States

Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States

Sylvester Comprehensive Cancer Center Miami, Florida, United States

View all 26 locations

View Trial Details

Recruiting

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

NCT06222203

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

NCT04222413

Conditions: Advanced Breast Cancer, Advanced Solid Tumors, Colonic Diseases, +32 more
Locations: University of Kansas Fairway, Kansas, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

NCT05253131

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +23 more
Locations: Children's of Alabama Birmingham, Alabama, United States

View Trial Details

Recruiting

SPEARHEAD-3 Pediatric Study

NCT05642455

Conditions: Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neoplasms, +26 more
Locations: Stanford University Palo Alto, California, United States

National Institutes of Health Bethesda, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Washington University St Louis, Missouri, United States

View Trial Details

Recruiting

Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor

NCT07549022

Conditions: Fibrosarcoma, MPNST, Malignant Peripheral Nerve Sheath Tumors, +15 more
Locations: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions: Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +82 more
Locations: Children's Healthcare of Atlanta Atlanta, Georgia, United States

Lurie Children's Hospital of Chicago Chicago, Illinois, United States

Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

NCT06735820

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +24 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

A Study of DEG6498 in Participants With Solid Tumors

NCT07244835

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +70 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Beijing GoBroad Hospital Beijing, Beijing Municipality, China

Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT04897321

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +65 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Neurofibrosarcoma

Neurofibrosarcoma trial results

Related conditions